Previous 10 | Next 10 |
2024-03-15 17:07:00 ET Ginkgo Bioworks (NYSE: DNA) has a lot going for it. It's a favorite of Cathie Wood's Ark Innovation ETF , it's a popular collaborator in the biopharma sector, and its positioning at the intersection of biotechnology, artificial intelligence (AI), and labor...
2024-03-13 07:17:14 ET More on Ginkgo Bioworks Holdings Ginkgo Bioworks: Multiple Red Flags Ginkgo Bioworks: More Awful Revenue Guidance Ginkgo Bioworks acquires Proof Diagnostics to expand gene editing service offerings Read the full article on Seeking Alp...
CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago PR Newswire The TGS program, a leading example of biosecurity infrastructure, operates at a total of nine US locations and leverages voluntary nasal swabs as wel...
2024-03-03 12:45:00 ET Could Ginkgo Bioworks Holdings (NYSE: DNA) one day be part of the healthcare sector's version of the "Magnificent Seven" group of high-performing stocks? It's more likely than you think. The Boston-based biofoundry has large aspirations to disrupt the way new ...
2024-03-01 12:21:52 ET Shares of Ginkgo Bioworks (NYSE: DNA) were sinking 9.5% lower as of 11:34 a.m. ET on Friday. The sell-off came after the biotechnology company announced its fourth-quarter and full-year 2023 results following the market close on Thursday. Ginkgo reported Q...
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire $251 million of Total revenue in 2023 $139 million in Cell Engineering services revenue, representing 31% growth over 2022 78 new Cell Programs added in 2023, repres...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
The Ginkgo Technology Network brings together over 25 diverse partners across an array of capabilities including AI, genetic medicines, biologics, and manufacturing. As a Ginkgo Technology Network partner, bit.bio’s ioCells™ portfolio of precision reprogrammed human cells fo...
Ginkgo Biosecurity Launches Doha-Based Pathogen Monitoring Center, CUBE-D, Establishing Middle East Hub for Global Bioradar, at Qatar Free Zones PR Newswire The center will be a first of its-kind collection and analysis center for data gathered through Ginkgo's pathogen monito...
Ginkgo Bioworks Announces Participation in the 44th Annual TD Cowen Health Care Conference PR Newswire BOSTON , Feb. 27, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today...
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Holdings Inc. Class A Company Name:
DNA Stock Symbol:
NYSE Market:
Ginkgo Bioworks Holdings Inc. Class A Website:
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals PR Newswire Syngenta will leverage Ginkgo's Ag Biologicals capabilities to optimize secondary metabolite production for a pioneering biological solution BASEL, Switzerland ...